Drug intelligence / Profile preview

Fuyang Yunshu Decoction

Development stage: Unknown
Lead developer: Guangdong Provincial Hospital of Traditional Chinese Medicine
Administration: Oral

Overview

Fuyang Yunshu Decoction is a traditional Chinese medicine (TCM) formulation developed by the Guangdong Provincial Hospital of Traditional Chinese Medicine. It is currently being investigated in clinical trials for its potential to treat obesity, metabolic syndrome, and associated insulin resistance. The decoction is administered orally, often in a granule formulation, and is designed to improve metabolic parameters and insulin sensitivity through the synergistic effects of its herbal components. The formulation is based on TCM principles aimed at regulating energetic imbalances (supporting Yang and moving the pivot) that contribute to metabolic dysfunction.

Other names: Fuyang YunshuFuyang Yunshu traditional Chinese medicine granules

Beyond the preview

Go deeper on Fuyang Yunshu Decoction.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Fuyang Yunshu Decoction.

Explore the full profile